# LivaNova acquires remaining stake in Caisson Interventional for $72M

LivaNova acquired the remaining stake in Caisson Interventional for $72 million, including milestone payments. LivaNova previously owned a 49% stake in Caisson, which develops a transcatheter mitral valve replacement device.

- Type: Acquisition
- Announced: 2017-05-02
- Where: Maple Grove, Minnesota, United States
- Value: $72.0M
- Status: completed
- Products: transcatheter mitral valve replacement implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LivaNova](https://endata.com/companies/8038.md) (acquirer)
- [Caisson Interventional](https://endata.com/companies/24023.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/livanova-buys-caisson-interventional-72m/), 2017-05-03: "We look forward to joining LivaNova to combine our efforts in bringing a superior technology to market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.